Tag search results
Tags let us describe our content with keywords, making it easier to find what you're most interested in. Use the search box to look for tags, or explore our coverage with the lists below.
Nearly 71,000 Americans died of drug overdoses last year, a new record that predates the COVID-19 crisis, which the White House and many experts believe will drive such deaths even higher.
An estimated 2.1 million people currently suffer from opioid use disorder nationwide. In Spokane County, rates of opioid overdose rank higher than the statewide average. Two decades into this crisis, the situation is dire, but far from hopeless.
The Spokane area needs more physicians willing to treat patients for opioid use disorder, local providers say, as barriers continue to exist for both patients and prescribers alike.
The federal judge overseeing the bankruptcy case of OxyContin maker Purdue Pharma set a June 30 deadline to file claims against the company
Washington filed its third lawsuit tied to the opioid crisis Thursday, claiming one of the nation’s biggest companies deceived doctors and patients about the addictive nature of the painkillers it developed and marketed.
More companies could investigate the efficacy of using the drug nalmefene (used primarily in the management of alcohol dependence) as another easy-to-use opioid overdose antidote under a deal announced Thursday by New York’s attorney general.
Drug overdose patients rushed to some emergency rooms in New York’s Hudson Valley are asked a series of questions: Do you have stable housing? Do you have food? Times and location of overdoses are noted, too.
The nation’s opioid addiction epidemic is driving new treatment strategies, including an approach that begins with rapid access to medicine that prevents withdrawal sickness.
Accidental overdoses cause 90% of all U.S. opioid-related deaths while suicides account for far fewer of these fatalities than previously thought, a new analysis published Tuesday suggests.
Members of the family that own OxyContin maker Purdue Pharma say they will push to reverse Tufts University’s decision to strip their name from campus facilities and programs
At least a half-dozen companies that make or distribute opioid painkillers are under a federal investigation of their role in a nationwide addiction and overdose crisis, according to a report.
An Oklahoma judge who last summer ordered consumer products giant Johnson & Johnson to pay $572 million to help address the state’s opioid crisis on Friday reduced that amount by $107 million in a final order he issued in the case.
The Trump administration has unveiled a website aimed at helping millions of Americans with substance abuse issues learn about and locate treatment options.
The nation’s three dominant drug distributors and a big drugmaker have reached a $260 million deal to settle a lawsuit related to the opioid crisis just as the first federal trial over the crisis was due to begin Monday.
Jury selection began Wednesday in the first federal trial over the opioid epidemic despite a last-minute request from lawyers to delay it because of news reports on a settlement offer.
A judge is pushing for a settlement of more than 2,600 lawsuits facing OxyContin maker Purdue Pharma with a decision Friday to pause litigation against the company and members of the wealthy Sackler family that owns the company.
The Spokane City Council is expected to approve a contract with a Seattle-based law firm that has brought multiple lawsuits against the manufacturers of opioid painkillers. The city’s legal department had previously advised against joining class action lawsuits.
Attorneys general representing nearly half the states and lawyers for more than 500 local governments on Friday blasted the terms of Purdue Pharma’s offer to settle thousands of lawsuits over the nation’s opioid crisis in court filings that also said the company had funneled up to $13 billion to its controlling family.
The tentative multibillion-dollar settlement with OxyContin maker Purdue Pharma would raise money to help clean up the opioid mess by … selling more OxyContin.
A judge has cleared the way for OxyContin maker Purdue Pharma to stay in business while it pursues bankruptcy protection and settlement of more than 2,600 lawsuits filed over the opioid crisis. Purdue lawyers secured permission Tuesday for the company to maintain business as usual. That includes paying employees and vendors, supplying pills to distributors, and keeping current on taxes and insurance.